Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Express Scripts
Federal Trade Commission
Cipla
Covington
Healthtrust
Citi
Argus Health
Mallinckrodt

Generated: June 20, 2018

DrugPatentWatch Database Preview

AUGMENTIN '250' Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Augmentin '250' patents expire, and when can generic versions of Augmentin '250' launch?

Augmentin '250' is a drug marketed by Dr Reddys Labs Inc and is included in three NDAs.

The generic ingredient in AUGMENTIN '250' is amoxicillin; clavulanate potassium. There are forty-five drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the amoxicillin; clavulanate potassium profile page.
Drug patent expirations by year for AUGMENTIN '250'
Pharmacology for AUGMENTIN '250'
Synonyms for AUGMENTIN '250'
2C16H19N3O5S.C8H8NO5.K
4-Oxa-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3-(2-hydroxyethylidene)-7-oxo-, monopotassium salt, (2R-(2-alpha,3Z,5-alpha))-, mixt. with (2S-(2-alpha,5-alpha,6-beta(S*)))-6-((amino(4-hydroxyphenyl)acetyl)amino)-3,3-dime
4-Oxa-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3-(2-hydroxyethylidene)-7-oxo-, monopotassium salt, (2R,3Z,5R)-, mixt. with (2S,5R,6R)-6-(((2R)-amino(4-hydroxyphenyl)acetyl)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.
4-Oxa-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3-(2-hydroxyethylidene)-7-oxo-,monopotassium salt, (2R-(2-alpha,3Z,5-alpha))-, mixt. with (2S-(2-alpha,5-alpha,6-beta(S*)))-6-((amino(4-hydroxyphenyl)acetyl)amino)-3,3-dimet
74428-36-7
74469-00-4
79198-29-1 (parent)
Amocla
Amoclan
Amoclav
Amoxi-Clavulanate
Amoxicillin / clavulanic acid
Amoxicillin clavulanate potassium
Amoxicillin mixed with potassium clavulanate (2:1)
Amoxicillin mixture with Clavulanate potassium
Amoxicillin-Clavulanic Acid
Amoxicillin-potassium clavulanate combination
AMOXICILLIN; CLAVULANATE POTASSIUM
Amoxsiklav
Amoxycillin-Clavulanic Acid
Ancla
Augmentan
Augmentin (antibiotic)
Augmentin XR
Augmentine
Auspilic
BRL 25000
BRL 25000A
BRL 25000G
BRL-25000
CHEMBL1697738
Clamentin
Clamobit
Clavam 625
Clavamox
Clavinex
Clavoxilin Plus
Clavulanate Potentiated Amoxycillin
Clavulin
Clavumox
Co-amoxiclav
Coamoxiclav
DTXSID40225477
DWHGNUUWCJZQHO-ZVDZYBSKSA-M
Eumetinex
HE385305
Kmoxilin
LS-187831
LS-98547
Potassium clavulanate mixed with amoxicillin (1:2)
Potassium Clavulanate-Amoxicillin Combination
SCHEMBL240728
Spectramox
Spektramox
Viaclav
Xiclav

US Patents and Regulatory Information for AUGMENTIN '250'

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dr Reddys Labs Inc AUGMENTIN '250' amoxicillin; clavulanate potassium FOR SUSPENSION;ORAL 050575-002 Aug 6, 1984 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Dr Reddys Labs Inc AUGMENTIN '250' amoxicillin; clavulanate potassium TABLET, CHEWABLE;ORAL 050597-002 Jul 22, 1985 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Dr Reddys Labs Inc AUGMENTIN '250' amoxicillin; clavulanate potassium TABLET;ORAL 050564-001 Aug 6, 1984 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Deloitte
Farmers Insurance
Healthtrust
US Department of Justice
Citi
McKinsey
Baxter
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.